Related Experiment Video
Updated: May 22, 2025
Complete and Partial Aortic Occlusion for the Treatment of Hemorrhagic Shock in Swine
Published on: August 24, 2018
Treatment of Noncompressible Torso Hemorrhage With Thermoreversible Intra-abdominal Foam: A Dose-response Study in a
Ross I Donaldson1, Aslam A Akhtar2, Oliver J Buchanan3
1Critical Innovations LLC, Los Angeles, California; Department of Emergency Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California; Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, California.
Introduction:
Noncompressible torso hemorrhage (NCTH) leads to significant mortality in civilian settings where transport to a trauma center may be delayed and is also the leading cause of exsanguination on the battlefield. Fast Onset Abdominal Management (F.O.A.M.) is a medical device under development that deploys a rapidly expanding thermoreversible foaming agent from a prefilled pressurized canister via an autostopping needle inserted into the peritoneal cavity. Previous pilot and safety studies in porcine models of NCTH have shown that F.O.A.M. increased survival and reached desired intra-abdominal pressure endpoints without significant adverse effects. However, the optimal intra-abdominal deployment pressure for the foaming agent is yet to be determined.
Methods:
In this prospective study, NCTH was modeled using a modified Ross-Burns swine model wherein a grade IV-V liver laceration was made in 40 animals. Each F.O.A.M. device was set to deliver agent to a preset intra-abdominal goal pressure. The pressure for the initial cohort was 60 mmHg and the experimental pressure for each subsequent cohort of animals was selected to be the pressure with the highest posterior probability of being the minimum effective pressure based on an ordinal Bayesian continual reassessment method.
Results:
After the allocation of animals to various pressures delivered by the F.O.A.M. device ranging between 50 and 80 mmHg, 33/40 swine had interpretable outcomes (e.g., technically successful device deployments). Based on a priori exclusion criteria, 7 animals were excluded from the analysis, four based on prototype device failure, and three based on off-target needle administration. At the final analysis, two pressures (70 mmHg and 80 mmHg) remained in the 95% credible interval.
Conclusions:
Pressure is the gold standard for effective tamponade of bleeding. In this dose-finding study of the F.O.A.M. device for intra-abdominal tamponade of NCTH in a porcine model, we found a 95% posterior probability that either 70 mmHg or 80 mmHg is the minimum effective pressure as defined in our model. Future studies will be needed to assess long-term survival and adverse events at this pressure.
